Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Heinzmann

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Parasite (Paris, France)|September 26, 2008
Evaluating parasite densities and estimation of parameters in transmission systemsD Heinzmann, P R Torgerson
Parasitology|February 28, 2008
Estimation of the transmission dynamics of Theileria equi and Babesia caballi in horsesS R Rüegg, D Heinzmann, A D Barbour, et al.
Experimental and Clinical Endocrinology|January 1, 1983
Decrease of glucose-induced insulin secretion of pancreatic rat islets after irradiation in vitroD Heinzmann, R Nadrowitz, W Besch, et al.
Parasitology|March 29, 2008
Case-control study to identify risk factors for bovine cysticercosis on farms in SwitzerlandF Flütsch, D Heinzmann, A Mathis, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 21, 2013
Trastuzumab retreatment after relapse on adjuvant trastuzumab therapy for human epidermal growth factor receptor 2-positive breast cancer: final results of the Retreatment after HErceptin Adjuvant trialI Láng, R Bell, F Y Feng, et al.
Cancer Chemotherapy and Pharmacology|November 2, 2013
A phase I, randomized, open-label study of the multiple-dose pharmacokinetics of vemurafenib in patients with BRAF V600E mutation-positive metastatic melanomaJ F Grippo, W Zhang, D Heinzmann, et al.
Herz|October 15, 2015
Efficacy and safety of zero-fluoroscopy ablation for supraventricular tachycardias. Use of optional contact force measurement for zero-fluoroscopy ablation in a clinical routine settingP Seizer, V Bucher, C Frische, et al.
ESMO Open|June 30, 2026
Higher rates of immune-related adverse events in circulating tumor DNA (ctDNA)-negative patients following adjuvant checkpoint inhibitor therapyT Powles, K Madjar, B I Balas, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Parasite (Paris, France)|September 26, 2008
Evaluating parasite densities and estimation of parameters in transmission systemsD Heinzmann, P R Torgerson
Parasitology|February 28, 2008
Estimation of the transmission dynamics of Theileria equi and Babesia caballi in horsesS R Rüegg, D Heinzmann, A D Barbour, et al.
Experimental and Clinical Endocrinology|January 1, 1983
Decrease of glucose-induced insulin secretion of pancreatic rat islets after irradiation in vitroD Heinzmann, R Nadrowitz, W Besch, et al.
Parasitology|March 29, 2008
Case-control study to identify risk factors for bovine cysticercosis on farms in SwitzerlandF Flütsch, D Heinzmann, A Mathis, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 21, 2013
Trastuzumab retreatment after relapse on adjuvant trastuzumab therapy for human epidermal growth factor receptor 2-positive breast cancer: final results of the Retreatment after HErceptin Adjuvant trialI Láng, R Bell, F Y Feng, et al.
Cancer Chemotherapy and Pharmacology|November 2, 2013
A phase I, randomized, open-label study of the multiple-dose pharmacokinetics of vemurafenib in patients with BRAF V600E mutation-positive metastatic melanomaJ F Grippo, W Zhang, D Heinzmann, et al.
Herz|October 15, 2015
Efficacy and safety of zero-fluoroscopy ablation for supraventricular tachycardias. Use of optional contact force measurement for zero-fluoroscopy ablation in a clinical routine settingP Seizer, V Bucher, C Frische, et al.
ESMO Open|June 30, 2026
Higher rates of immune-related adverse events in circulating tumor DNA (ctDNA)-negative patients following adjuvant checkpoint inhibitor therapyT Powles, K Madjar, B I Balas, et al.
Pageof 1